Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 29 tags : Application save search
Universal Technical Institute and Ignite Worldwide $100,000 Grant Program for Women Entering STEM Fields Now Accepting Applications
Published: 2021-11-29 (Crawled : 21:00) - prnewswire.com
UTI | $14.62 0.69% 0.0% 350K
|
Commercial Services
|
| O: 0.87%
H: 4.06%
C: 3.45%
application women granted
Global Atomic Spectroscopy Market (2021 to 2026) - by Application, Technology and Geography
Published: 2021-11-29 (Crawled : 18:00) - prnewswire.com
DHR | $250.41 -1.07% -0.46% 2.3M
|
Health Technology
|
| O: 0.74%
H: 1.9%
C: 0.99%
BRKR | $82.2 -0.32% -0.3% 990K
|
Health Technology
|
| O: -1.49%
H: 3.09%
C: 0.68%
application technology
Athenex Announces UK MHRA Validation of the Marketing Authorization Application for Oral Paclitaxel and Encequidar for Review
Published: 2021-11-29 (Crawled : 14:30) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
application
Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric and Gastroesophageal Junction Cancer
Published: 2021-11-29 (Crawled : 14:30) - biospace.com/
CELU | News 4 | $3.38 5.3% 5.17% 36K
|
|
| O: 1.48%
H: 2.19%
C: -2.19%
new drug fda clearance application drug fda clearance positive therapy cancer her2- her2
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
Published: 2021-11-29 (Crawled : 13:00) - globenewswire.com
VRCA | $6.79 -0.88% -0.74% 110K
|
Health Technology
|
| O: -5.72%
H: 5.02%
C: -0.09%
molluscum new drug treatment application drug submission resubmission
Immunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
Published: 2021-11-29 (Crawled : 12:30) - biospace.com/
IMNM | $14.27 -2.66% -2.66% 560K
|
Health Technology
|
| O: 7.88%
H: 13.26%
C: 12.55%
covid new drug treatment application drug submission
Bristol Myers Squibb’s Applications for Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis Accepted by U.S. Food and Drug Administration and Validated by European Medicines Agency
Published: 2021-11-29 (Crawled : 12:30) - biospace.com/
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -1.18%
H: 1.16%
C: 0.49%
psoriasis food treatment europe application drug plague
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
Published: 2021-11-29 (Crawled : 12:00) - biospace.com/
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -50.05%
H: 0.0%
C: 0.0%
new drug fda solid tumors application drug
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.